Religare Enterprises Receives NSE & BSE Clearance for Demerger Scheme; Moves Closer to NCLT Approval

What Happened ?

Key Details

Prototype Milestone:

• NSE issued its Observation Letter carrying “No Objection.”
• BSE issued its Observation Letter carrying “No Adverse Observations.”
• The observation letters were received on July 07, 2026.
• The scheme can now be filed before the National Company Law Tribunal (NCLT).  

Proposed Scheme:

• Scheme of Arrangement between:
  • Religare Enterprises Limited (Demerged Company)
  • Religare Finvest Limited (Resulting Company)
• Proposed under Sections 230–232, read with Sections 52 and 66 of the Companies Act, 2013.
• Intended to reorganize the corporate structure through a demerger.  

Important Conditions:

The exchanges have advised the company to ensure:

• Full disclosure of pending legal, regulatory and enforcement proceedings.
• Updated information is displayed on the company’s website.
• Compliance with all applicable SEBI circulars.
• Transfer of liabilities to the resulting company in accordance with the scheme.
• Shareholder notices include detailed rationale, valuation methodology, swap ratio basis, financial implications, benefits, risks and regulatory approvals.
• Compliance with Companies Act provisions and creditor approvals.
• Proposed shares, if issued, will be in dematerialised form only.  

Timeline:

• The NSE Observation Letter remains valid for six months from July 07, 2026.
• The company must file the scheme before the NCLT within this validity period.
• If approved by the NCLT, the listing process for Religare Finvest Limited is expected to be completed within the timelines prescribed under SEBI regulations.  

Note:

• The stock exchange observation letters do not constitute final approval of the Scheme. The restructuring will become effective only after receiving all statutory approvals, shareholder and creditor consent, and sanction from the National Company Law Tribunal.  

Risk Analysis

Summary:

• While the regulatory observations are a significant procedural milestone, the demerger remains subject to several approvals and execution requirements before implementation.

Key Risks:

• NCLT approval is still pending.
• Shareholder and creditor approvals are required.
• Regulatory conditions prescribed by NSE, BSE and SEBI must be fully complied with.
• Any delay in approvals may postpone completion of the restructuring.

Worst Case:

• Failure to obtain statutory approvals or comply with regulatory conditions could delay, modify, or prevent implementation of the proposed Scheme of Arrangement.

Risk Level: Medium

Company Commentary

• Religare Enterprises confirmed receipt of the NSE and BSE observation letters on July 07, 2026.
• The company stated that the Scheme remains subject to statutory, regulatory, shareholder and creditor approvals.
• Copies of the observation letters have been hosted on the company’s website.
• The company requested the stock exchanges to treat the disclosure as compliance with Regulation 30 of the SEBI (LODR) Regulations.